Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis

Summary

The goal of this study is to learn if emvistegrast (formerly GS-1427) is effective in treating participants with moderate to severe ulcerative colitis. The study will compare participants in different treatment groups treated with emvistegrast with participants treated with placebo. The primary objective of this study is to assess the efficacy of emvistegrast, compared with placebo control, in achieving clinical response at Week 12.

Timeline

Start

2024-03-27

Primary completion

2026-03-04

Completion

2028-04

Drugs

Indications